Papers
1
Total Citations
5
H-Index
1
About
Dr. Ky Trinh is a translational virologist whose work bridges the gap between fundamental research and clinical diagnostics, with a primary focus on emerging viral pathogens and serological assay development. Dr. Trinh’s most notable contribution is the creation of an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay, a critical tool for monitoring neutralizing antibodies against SARS-CoV-2 and its variants of concern. This work, published in 2023, provides a reliable and efficient method for assessing vaccine efficacy and immune durability, directly supporting public health responses during the pandemic. By engineering a highly attenuated SARS-CoV-2 strain (Δ3678_WA1-s), Dr. Trinh enabled safe, high-throughput testing outside of high-containment facilities, significantly expanding access to neutralization data. While early in their career, this foundational platform has already garnered 5 citations, underscoring its immediate utility. Dr. Trinh’s research is essential for students and researchers interested in virology, assay development, and the practical application of biosafety principles to combat emerging infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1